Palpable mass after Milbemycin Oxime + Spinosad (Trifexis) in dogs

143 reports to the FDA describe palpable mass in dogs given Milbemycin Oxime + Spinosad. That is 0.1% of all reports for this medicine, compared with 0.1% across reports for all dog medicines, so it is reported unusually often with this medicine.

143Reports
75%Marked serious
33%Recovered
15%Died or euthanised
46 daysTypical onset
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

How soon it started

Same day
17 23%
1–2 days
4 5.3%
3–7 days
4 5.3%
1–4 weeks
7 9.3%
Over a month
43 57%

How the animals did

Recovered
22 15%
Recovered with lasting effects
25 17%
Still unwell when reported
31 22%
Died
9 6.3%
Euthanised
12 8.4%
Not known
44 31%

Problems reported at the same time

Age of the animals

Under 1 year
5
1–3 years
14
4–7 years
40
8–11 years
49
12+ years
32

About this medicine

Milbemycin Oxime prevents heartworm and controls some intestinal worms (monthly). Spinosad kills fleas; monthly chewable.

Products with this combination include Trifexis. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Some herding breeds (for example Collies) carry the MDR1 gene variant and can be more sensitive to this drug class at high doses.

Questions owners ask

Can Milbemycin Oxime + Spinosad cause palpable mass in dogs?
143 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?
In half of the reports with dates, it started within 46 days of the first dose.
What should I do?
Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Palpable mass with similar medicines

All reported side effects of Milbemycin Oxime + Spinosad in dogs · Medicines most reported with palpable mass